For dementia biomarkers such as Aβ and T‐tau, previous studies demonstrated that in the cerebrospinal fluid or blood they change far before the onset of neurodegenerative symptoms, which may have not been detectable by imaging method yet (Bateman, Xiong, Benzinger, Fagan, & Goate, 2012). Here, MAPT is linked to dementia.